A new study from Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh reveals that nearly 37% of ...

Rosen's excitement about AI stems from the ability to move beyond population health theories to deliver truly individualized ...

AI transforms cancer treatment by personalizing care and enhancing patient-provider communication, revolutionizing how patients manage their health.

Google has been accused of promoting fake pension news to Britons after showing spam websites with misleading information at ...

Resmed Inc (($RMD)) announced an update on their ongoing clinical study. Study Overview: ResMed Inc is conducting a study titled ‘Evaluation of a ...

A car is understood to have struck a large road sign before crashing and flipping over onto its roof. The wreckage was left ...

A woman was taken to hospital with 'serious injuries' after a collision with a car on Friday. Emergency services were called ...

Begin with connectivity. AI requires internet access. Although nine in ten people in rich countries were online in 2024, only ...

The European Association for the Study of Obesity recommends the GLP-1 injectables semaglutide and tirzepatide as first-line treatments for most cases of obesity. This is due to their higher efficacy ...

The European Association for the Study of Obesity now recommends the 2 treatments for obesity and most associated complications. According to an EASO news release, these new recommendations reflect ...

Most effective drugs for obesity and its complications are semaglutide, tirzepatide, new European guideline says Certain GLP-1 drugs are best for specific complications The non-binding guideline ...

Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...